- Home
- TREE vs NKTR Comparison
TREE vs NKTR Comparison
Compare TREE & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- NKTR
- Stock Information
- Founded
- TREE 1996
- NKTR 1990
- Country
- TREE United States
- NKTR United States
- Employees
- TREE N/A
- NKTR N/A
- Industry
- TREE Finance: Consumer Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- TREE Finance
- NKTR Health Care
- Exchange
- TREE Nasdaq
- NKTR Nasdaq
- Market Cap
- TREE 978.1M
- NKTR 1.2B
- IPO Year
- TREE N/A
- NKTR 1994
- Fundamental
- Price
- TREE $60.68
- NKTR $60.34
- Analyst Decision
- TREE Buy
- NKTR Strong Buy
- Analyst Count
- TREE 8
- NKTR 6
- Target Price
- TREE $65.38
- NKTR $91.67
- AVG Volume (30 Days)
- TREE 220.6K
- NKTR 877.0K
- Earning Date
- TREE 10-30-2025
- NKTR 11-06-2025
- Dividend Yield
- TREE N/A
- NKTR N/A
- EPS Growth
- TREE N/A
- NKTR N/A
- EPS
- TREE N/A
- NKTR N/A
- Revenue
- TREE $1,012,155,000.00
- NKTR $74,934,000.00
- Revenue This Year
- TREE $17.19
- NKTR N/A
- Revenue Next Year
- TREE $7.58
- NKTR N/A
- P/E Ratio
- TREE N/A
- NKTR N/A
- Revenue Growth
- TREE 51.65
- NKTR N/A
- 52 Week Low
- TREE $33.50
- NKTR $6.48
- 52 Week High
- TREE $77.35
- NKTR $65.79
- Technical
- Relative Strength Index (RSI)
- TREE 48.27
- NKTR 57.28
- Support Level
- TREE $55.94
- NKTR $59.55
- Resistance Level
- TREE $63.67
- NKTR $65.79
- Average True Range (ATR)
- TREE 2.75
- NKTR 4.14
- MACD
- TREE 0.56
- NKTR -0.44
- Stochastic Oscillator
- TREE 79.04
- NKTR 60.09
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.